339 related articles for article (PubMed ID: 35579811)
1. Machine Learning in Causal Inference: Application in Pharmacovigilance.
Zhao Y; Yu Y; Wang H; Li Y; Deng Y; Jiang G; Luo Y
Drug Saf; 2022 May; 45(5):459-476. PubMed ID: 35579811
[TBL] [Abstract][Full Text] [Related]
2. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System.
Kreimeyer K; Dang O; Spiker J; Muñoz MA; Rosner G; Ball R; Botsis T
Comput Biol Med; 2021 Aug; 135():104517. PubMed ID: 34130003
[TBL] [Abstract][Full Text] [Related]
3. Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.
Malec SA; Wei P; Bernstam EV; Boyce RD; Cohen T
J Biomed Inform; 2021 May; 117():103719. PubMed ID: 33716168
[TBL] [Abstract][Full Text] [Related]
4. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
[TBL] [Abstract][Full Text] [Related]
5. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional Encoder Representations from Transformers-like large language models in patient safety and pharmacovigilance: A comprehensive assessment of causal inference implications.
Wang X; Xu X; Liu Z; Tong W
Exp Biol Med (Maywood); 2023 Nov; 248(21):1908-1917. PubMed ID: 38084745
[TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence, Causal Inference, and Machine Learning.
Crown WH
Value Health; 2019 May; 22(5):587-592. PubMed ID: 31104739
[TBL] [Abstract][Full Text] [Related]
8. Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions.
Cherkas Y; Ide J; van Stekelenborg J
Drug Saf; 2022 May; 45(5):571-582. PubMed ID: 35579819
[TBL] [Abstract][Full Text] [Related]
9. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
10. Machine learning on adverse drug reactions for pharmacovigilance.
Lee CY; Chen YP
Drug Discov Today; 2019 Jul; 24(7):1332-1343. PubMed ID: 30876845
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
[TBL] [Abstract][Full Text] [Related]
12. Reflection on modern methods: when worlds collide-prediction, machine learning and causal inference.
Blakely T; Lynch J; Simons K; Bentley R; Rose S
Int J Epidemiol; 2021 Jan; 49(6):2058-2064. PubMed ID: 31298274
[TBL] [Abstract][Full Text] [Related]
13. Developing a novel causal inference algorithm for personalized biomedical causal graph learning using meta machine learning.
Wu H; Shi W; Wang MD
BMC Med Inform Decis Mak; 2024 May; 24(1):137. PubMed ID: 38802809
[TBL] [Abstract][Full Text] [Related]
14. Invited Commentary: Machine Learning in Causal Inference-How Do I Love Thee? Let Me Count the Ways.
Balzer LB; Petersen ML
Am J Epidemiol; 2021 Aug; 190(8):1483-1487. PubMed ID: 33751059
[TBL] [Abstract][Full Text] [Related]
15. Learning Causal Effects From Observational Data in Healthcare: A Review and Summary.
Shi J; Norgeot B
Front Med (Lausanne); 2022; 9():864882. PubMed ID: 35872797
[TBL] [Abstract][Full Text] [Related]
16. Machine learning in the estimation of causal effects: targeted minimum loss-based estimation and double/debiased machine learning.
Díaz I
Biostatistics; 2020 Apr; 21(2):353-358. PubMed ID: 31742333
[TBL] [Abstract][Full Text] [Related]
17. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.
Song D; Chen Y; Min Q; Sun Q; Ye K; Zhou C; Yuan S; Sun Z; Liao J
J Clin Pharm Ther; 2019 Apr; 44(2):268-275. PubMed ID: 30565313
[TBL] [Abstract][Full Text] [Related]
18. Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.
Gavriilidis GI; Dimitriadis VK; Jaulent MC; Natsiavas P
Drug Saf; 2021 Nov; 44(11):1165-1178. PubMed ID: 34674190
[TBL] [Abstract][Full Text] [Related]
19. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
[TBL] [Abstract][Full Text] [Related]
20. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.
Eshleman R; Singh R
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):335. PubMed ID: 27766937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
